Member Info for Laura2022

Just made over 200% on that since buying before Christmas

Can see VAL doing similar

Pyc are the "FOREFRONT " as you said quite rightly from December news feed

significant expansion of the ongoing collaboration between Physiomics and its client, marking the first incorporation of an Antibody-Drug Conjugate ("ADC") into the company's Virtual Tumour ("VT") modelling platform. ADCs are a rapidly advancing class of targeted therapies in oncology, offering enhanced precision by enabling tumour specific delivery of potent cytotoxic payloads. This project positions Physiomics at the forefront of this exciting field of drug development.

That we are still only £1.7mln cap when CEO takes lowesr salary on AIM and we have beaten revenue targets for full year 2024 and for H1 for this year

This yeara revenues could be more than the market cap

No debt too

Well found KingH

Understandable

What a brilliant day for everyone

VAL PYC next

Fonzi

Well done, yes here on my lonesome for last 3mths :)

BasilAlderman

Posted in: PYC

Posts: 1,377

Price: 0.90

No Opinion

RE: REACH RNS out8 Jan 2025 09:49

Yes and a pertinent reminder of my post from 12.12.24 about the PWC report that Iano has reposted recently too. i.e. our MCAP is peanuts for what is evolving here. More like £200 Million for starters in our space. A recap on why PYC is so under valued:

1. Dealmakers in pharmaceuticals and life sciences and in healthcare services are eager to get deals done.

2. Competition for truly innovative assets remains intense.

3. Large pharmaceutical companies will continue to pursue biotech targets and products that can offset revenue declines from lost exclusivity in the coming years.

4. Companies seeking opportunities to digitalise through implementation of analytics technology, digital direct-to-consumer therapeutics offerings, smart health devices and other software innovations will continue to acquire or partner with data and analytics and other technology companies that can deliver these digital solutions.

For example:

5. Merck: Acquired Harpoon Therapeutics for an estimated $680 million

6. Novartis: Acquired Calypso Biotech for $250 million

7. Aditxt: Acquired Evofem Biosciences for $100 million

8. There were 420 M&A deals in our sector globally in Q3 2024, worth a total value of $32.4bn. Source: GlobalData’s Deals Database.

9. The $3.2bn acquisition of Morphic Holdings by Eli Lilly and Co was the industry’s largest disclosed deal in Q3 2024.

10. Interestingly for PYC investors AI / State of the art virtual technology accounted for 11 pharmaceutical deals announced in Q3 2024, worth a total value of $1.7bn. The $1.1bn acquisition of Integrated Oncology Network by Cardinal Health was the industry’s largest disclosed deal.

https://www.pwc.com/gx/en/services/deals/trends/health-industries.html

PYC which is also in the hot bio tech and A.I sector

Summary below

£1.5mln cap

£600-700k cash ,no debt small losses

CE0 salary £72k is 1/4 of AIM average = modest and alligned

Record contracts won June 2023 to June 2024 £1mln

Record revenues going into end of H1 2024 of currently £800-900k (up to Dec 2024)

Only needs about £1.4mln FY revenues end of June 2025 to probably turn to profit

Working in niche A.I software development market worth $blns

New CEO made huge impact in just 9mths

Potentially very large bio statistic contracts to come (words of BOD at last presentation)

Access to EU and USA markets via NASDAQ partners

VAL confirmed 31st Dec that the out licence of VAL201 which PYC collaboration on will have further details soon ( see VAL RNS 31st Dec) 6

LOTM

Thanks and yes, each purchase was documented here over last 3mths

Flight man

Pleasure , it took a while ( 3mths) but I was confident in the emails I received amd the public RNS

Have a look at 08.08am summary of PYC

Laura2022

Posts: 6,963

Price: 0.65

No Opinion

RE: £1mln cap V c.$5mln cash as of Dec8 Dec 2024 15:06

I'm seeing a large move this week .they will constantly take 1.5mln well above bid and yet will go NT to buy often

Don't miss my other A.I/bio tech small caps PYC

Whoever he is

I was saying this in Nov/Dec 2024

I recommend looking at information from

Trench123

Kinghomer

Basilalderman

Troutisout

Amongst others

Some good pointers last 3 weeks on this discussion group

Large buy then

Sharehog

A move like TRLS which i was buying at 0.65p (now 350% up) based on fundamentals

PYC at £1 5mln cap is ridiculously undervalued ( see previous threads and RNS)

Hope that helps

Nice to hear fundamental

My next tip is 08.08am on this thread

Awesome day

2mths ago there was 1 post and 3 trades a day

What a change

Best wishes , hope everyone did well from my tip here at 0.65p

Just shown

Buy

10% up